Announcements Trials

Browse Landscape

Phase

Status

Completed 12 Terminated 3 Recruiting 3 Withdrawn 2 Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

Carboplatin 127 Cisplatin 125 Drug Therapy 117 Bevacizumab 102 Oxaliplatin 99 Capecitabine 99 Radiotherapy 97 Gemcitabine 87 tislelizumab 86 Paclitaxel 86 Cyclophosphamide 86 Specimen Handling 80 pembrolizumab 76 toripalimab 68 Magnetic Resonance Spectroscopy 65 Fluorouracil 63 Injections 62 sintilimab 58 Surgical Procedures, Operative 58 anlotinib 53 Docetaxel 52 130-nm albumin-bound paclitaxel 50 fludarabine 47 Standard of Care 46 Pemetrexed 45 Immune Checkpoint Inhibitors 45 Blood Specimen Collection 43 Biopsy 43 venetoclax 42 Leucovorin 42

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × 5-aminolevulinic acid hexyl ester × Clear all

NCT06548438 2024-08-12

TUR_BLUE

A.O.U. Città della Salute e della Scienza

Phase 4 Not yet recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡